vs
亚什兰（ASH）与Orion Group Holdings Inc（ORN）财务数据对比。点击上方公司名可切换其他公司
亚什兰的季度营收约是Orion Group Holdings Inc的1.8倍（$386.0M vs $216.3M），Orion Group Holdings Inc净利率更高（2.2% vs -3.1%，领先5.3%），Orion Group Holdings Inc同比增速更快（14.6% vs -4.7%），过去两年Orion Group Holdings Inc的营收复合增速更高（6.1% vs -18.1%）
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
奥里昂集团是源自芬兰的全球化制药企业，1917年成立，总部位于芬兰埃斯波。公司面向全球市场研发、生产并销售人用与兽用药品以及药用活性成分，旗下全部生产基地与大部分研发部门均设立在芬兰。
ASH vs ORN — 直观对比
营收规模更大
ASH
是对方的1.8倍
$216.3M
营收增速更快
ORN
高出19.3%
-4.7%
净利率更高
ORN
高出5.3%
-3.1%
两年增速更快
ORN
近两年复合增速
-18.1%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $386.0M | $216.3M |
| 净利润 | $-12.0M | $4.7M |
| 毛利率 | 27.2% | 12.0% |
| 营业利润率 | -1.6% | — |
| 净利率 | -3.1% | 2.2% |
| 营收同比 | -4.7% | 14.6% |
| 净利润同比 | 92.7% | 435.7% |
| 每股收益（稀释后） | $-0.26 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASHORN
| Q1 26 | — | $216.3M | ||
| Q4 25 | $386.0M | $233.2M | ||
| Q3 25 | $477.0M | $225.1M | ||
| Q2 25 | $463.0M | $205.3M | ||
| Q1 25 | $479.0M | $188.7M | ||
| Q4 24 | $405.0M | $216.9M | ||
| Q3 24 | $521.0M | $226.7M | ||
| Q2 24 | $544.0M | $192.2M |
净利润ASHORN
| Q1 26 | — | $4.7M | ||
| Q4 25 | $-12.0M | $-240.0K | ||
| Q3 25 | $31.0M | $3.3M | ||
| Q2 25 | $-742.0M | $841.0K | ||
| Q1 25 | $31.0M | $-1.4M | ||
| Q4 24 | $-165.0M | $6.8M | ||
| Q3 24 | $17.0M | $4.3M | ||
| Q2 24 | $6.0M | $-6.6M |
毛利率ASHORN
| Q1 26 | — | 12.0% | ||
| Q4 25 | 27.2% | 11.6% | ||
| Q3 25 | 33.3% | 13.2% | ||
| Q2 25 | 28.5% | 12.6% | ||
| Q1 25 | 30.7% | 12.2% | ||
| Q4 24 | 27.4% | 14.0% | ||
| Q3 24 | 33.2% | 11.9% | ||
| Q2 24 | 34.2% | 9.5% |
营业利润率ASHORN
| Q1 26 | — | — | ||
| Q4 25 | -1.6% | 2.2% | ||
| Q3 25 | 12.8% | 2.4% | ||
| Q2 25 | -152.9% | 1.7% | ||
| Q1 25 | 10.6% | 0.4% | ||
| Q4 24 | -44.2% | 4.4% | ||
| Q3 24 | 6.1% | 3.4% | ||
| Q2 24 | -11.2% | -1.4% |
净利率ASHORN
| Q1 26 | — | 2.2% | ||
| Q4 25 | -3.1% | -0.1% | ||
| Q3 25 | 6.5% | 1.5% | ||
| Q2 25 | -160.3% | 0.4% | ||
| Q1 25 | 6.5% | -0.7% | ||
| Q4 24 | -40.7% | 3.1% | ||
| Q3 24 | 3.3% | 1.9% | ||
| Q2 24 | 1.1% | -3.4% |
每股收益（稀释后）ASHORN
| Q1 26 | — | $0.12 | ||
| Q4 25 | $-0.26 | $-0.00 | ||
| Q3 25 | $0.83 | $0.08 | ||
| Q2 25 | $-16.21 | $0.02 | ||
| Q1 25 | $0.65 | $-0.04 | ||
| Q4 24 | $-3.50 | $0.22 | ||
| Q3 24 | $0.34 | $0.12 | ||
| Q2 24 | $0.12 | $-0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | $6.3M |
| 总债务越低越好 | $1.4B | — |
| 股东权益账面价值 | $1.9B | $166.7M |
| 总资产 | $4.5B | $478.7M |
| 负债/权益比越低杠杆越低 | 0.74× | — |
8季度趋势，按日历期对齐
现金及短期投资ASHORN
| Q1 26 | — | $6.3M | ||
| Q4 25 | $304.0M | $1.6M | ||
| Q3 25 | $215.0M | $4.9M | ||
| Q2 25 | $207.0M | $1.7M | ||
| Q1 25 | $168.0M | $13.0M | ||
| Q4 24 | $219.0M | $28.3M | ||
| Q3 24 | $300.0M | $28.3M | ||
| Q2 24 | $399.0M | $4.8M |
总债务ASHORN
| Q1 26 | — | — | ||
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | $33.4M | ||
| Q1 25 | $1.3B | $23.3M | ||
| Q4 24 | $1.3B | $23.2M | ||
| Q3 24 | $1.3B | $28.0M | ||
| Q2 24 | $1.3B | $60.3M |
股东权益ASHORN
| Q1 26 | — | $166.7M | ||
| Q4 25 | $1.9B | $159.0M | ||
| Q3 25 | $1.9B | $157.9M | ||
| Q2 25 | $1.9B | $153.2M | ||
| Q1 25 | $2.6B | $150.8M | ||
| Q4 24 | $2.6B | $150.7M | ||
| Q3 24 | $2.9B | $142.4M | ||
| Q2 24 | $3.0B | $111.1M |
总资产ASHORN
| Q1 26 | — | $478.7M | ||
| Q4 25 | $4.5B | $414.7M | ||
| Q3 25 | $4.6B | $422.4M | ||
| Q2 25 | $4.6B | $432.7M | ||
| Q1 25 | $5.2B | $416.3M | ||
| Q4 24 | $5.2B | $417.3M | ||
| Q3 24 | $5.6B | $430.3M | ||
| Q2 24 | $5.7B | $414.0M |
负债/权益比ASHORN
| Q1 26 | — | — | ||
| Q4 25 | 0.74× | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.73× | 0.22× | ||
| Q1 25 | 0.52× | 0.15× | ||
| Q4 24 | 0.51× | 0.15× | ||
| Q3 24 | 0.47× | 0.20× | ||
| Q2 24 | 0.45× | 0.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.0M | — |
| 自由现金流经营现金流 - 资本支出 | $111.0M | — |
| 自由现金流率自由现金流/营收 | 28.8% | — |
| 资本支出强度资本支出/营收 | 3.6% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $200.0M | — |
8季度趋势，按日历期对齐
经营现金流ASHORN
| Q1 26 | — | — | ||
| Q4 25 | $125.0M | $13.8M | ||
| Q3 25 | $40.0M | $23.3M | ||
| Q2 25 | $115.0M | $-5.6M | ||
| Q1 25 | $9.0M | $-3.4M | ||
| Q4 24 | $-30.0M | $13.4M | ||
| Q3 24 | $80.0M | $37.5M | ||
| Q2 24 | $127.0M | $-15.3M |
自由现金流ASHORN
| Q1 26 | — | — | ||
| Q4 25 | $111.0M | $454.0K | ||
| Q3 25 | $6.0M | $13.9M | ||
| Q2 25 | $95.0M | $-12.7M | ||
| Q1 25 | $-12.0M | $-12.5M | ||
| Q4 24 | $-53.0M | $9.9M | ||
| Q3 24 | $42.0M | $33.3M | ||
| Q2 24 | $98.0M | $-20.0M |
自由现金流率ASHORN
| Q1 26 | — | — | ||
| Q4 25 | 28.8% | 0.2% | ||
| Q3 25 | 1.3% | 6.2% | ||
| Q2 25 | 20.5% | -6.2% | ||
| Q1 25 | -2.5% | -6.6% | ||
| Q4 24 | -13.1% | 4.6% | ||
| Q3 24 | 8.1% | 14.7% | ||
| Q2 24 | 18.0% | -10.4% |
资本支出强度ASHORN
| Q1 26 | — | — | ||
| Q4 25 | 3.6% | 5.7% | ||
| Q3 25 | 7.1% | 4.2% | ||
| Q2 25 | 4.3% | 3.5% | ||
| Q1 25 | 4.4% | 4.8% | ||
| Q4 24 | 5.7% | 1.6% | ||
| Q3 24 | 7.3% | 1.8% | ||
| Q2 24 | 5.3% | 2.4% |
现金转化率ASHORN
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.29× | 7.05× | ||
| Q2 25 | — | -6.61× | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | — | 1.98× | ||
| Q3 24 | 4.71× | 8.79× | ||
| Q2 24 | 21.17× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
ORN
暂无分部数据
